Indian benchmark indices experienced their sharpest decline in over a month, weighed down by uncertainty surrounding the U.S.

Novo Nordisk NVO is expected to beat estimates when it reports third-quarter 2024 results on Nov. 6, before the opening bell.

In early education, for instance, the number of full-day pre-school places has increased to more than 200,000 to meet demand ...

The Labour Party has won a landslide victory in the 2024 general election. The party has taken 412 seats giving it a majority of 174. It is the worst Conservative result in terms of seats in ...

The study reveals a dose-response relationship between BMI and PASC risk in children, highlighting obesity as a key factor in post-COVID health challenges.

Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024 Selected for late-breaking oral presentation at ASN kidney week, the world ...

Acquisition creates a leading, clinical-stage company focused on the development of gene therapy treatments for rare inherited retinal degenerations New OPGx-LCA5 Phase 1/2 6-month data demonstrate sa ...

The biopharmaceutical industry is thriving, fueled by groundbreaking advancements in treating cancers, Alzheimer’s, obesity, diabetes, and autoimmune diseases ... year over year and beat Wall Street’s ...

Cholesterol control is essential during festive season. Here are how one can reduce risk of sudden LDL spike and heart attack.

Novo Nordisk NVO announced positive top-line data from a late-stage cardiovascular outcomes study that evaluated its oral ...

Only a blood test can tell if you are pre-diabetic or not, but lifestyle changes, in particular improving diet quality, are key to preventing and even reversing T2D. One study, which analysed 4.1 ...

Jeanette Beebe is an experienced journalist, fact-checker, and audio producer covering personal finance, retirement, science, business, medicine, technology, and the arts. Her reporting has ...